Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning
C L Cameron, D Cella, J E Herndon, et al.
Cancer
|
January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B
N I Nissen, T F Pajak, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study
M Perloff, L Norton, A H Korzun, et al.
Leukemia
|
February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S Koschmieder, T I Mughal, H C Hasselbalch, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1981
Resistance to therapy of acute leukemia developing in the course of polycythemia vera
P B Donovan, S A Landaw, C Dresch, et al.
The Cancer Journal From Scientific American
|
November 1, 1995
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy
D H Henry, B J Brooks, D C Case, et al.
Blood Cancer Journal
|
March 9, 2013
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
A Tefferi, O Abdel-Wahab, F Cervantes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 1998
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B
A B Kornblith, J E Herndon, E Zuckerman, et al.
Cancer
|
August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease
M R Cooper, T F Pajak, N I Nissen, et al.
Leukemia
|
April 11, 2008
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
A Hochhaus, M Baccarani, M Deininger, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning
C L Cameron, D Cella, J E Herndon, et al.
Cancer
|
January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B
N I Nissen, T F Pajak, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study
M Perloff, L Norton, A H Korzun, et al.
Leukemia
|
February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S Koschmieder, T I Mughal, H C Hasselbalch, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1981
Resistance to therapy of acute leukemia developing in the course of polycythemia vera
P B Donovan, S A Landaw, C Dresch, et al.
The Cancer Journal From Scientific American
|
November 1, 1995
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy
D H Henry, B J Brooks, D C Case, et al.
Blood Cancer Journal
|
March 9, 2013
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
A Tefferi, O Abdel-Wahab, F Cervantes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 1998
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B
A B Kornblith, J E Herndon, E Zuckerman, et al.
Cancer
|
August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease
M R Cooper, T F Pajak, N I Nissen, et al.
Leukemia
|
April 11, 2008
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
A Hochhaus, M Baccarani, M Deininger, et al.
Page
of 14